Page 37 - 01.pdf

CONSOLIDATED INCOME STATEMENT
FOR THE FINANCIAL YEAR ENDED 31 DECEMBER 2013
Note 2013 2012
$ $
Revenue 4 14,683,307 11,885,307
Other income 176,132 75,375
Items of expense
Consumables used (1,426,767) (945,686)
Employee benefits expense 30 (6,218,397) (4,819,768)
Depreciation of property, plant and equipment 9 (1,196,248) (1,308,795)
Operating lease expenses (1,351,989) (1,155,922)
Maintenance of equipment (716,436) (730,432)
Laboratory and consultancy fees (2,121,990) (1,580,376)
Finance costs 5 (72,783) (40,634)
Other operating expenses (2,270,627) (1,562,501)
Share of results of associates 457,683 236,316
(Loss)/profit before income tax 6 (58,115) 52,884
Income tax credit/(expense) 7 122,769 (18,961)
Profit for the year 64,654 33,923
Attributable to:
Owners of the Company 53,946 79,613
Non-controlling interests 10,708 (45,690)
64,654 33,923
Earnings per share (cents per share)
Basic 8 0.02 0.02
Diluted 8 0.02 0.02
The accompanying accounting policies and explanatory notes form an integral part of the financial statements.
ASIAMEDIC LIMITED
ANNUAL REPORT 2013 35